#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastatic malignant melanoma Pneumonia Parkinson's disease Paget's disease of the vulva B-cell lymphoma Oesophageal carcinoma Diabetes insipidus Acquired ATTR amyloidosis Vulval cancer Hypochondroplasia Synovial sarcoma Guillain-Barre syndrome Heart disease congenital Neuroblastoma Biliary neoplasm More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome – Treatment Bronchiolitis obliterans syndrome – Trials in Disease Haemophilia A without inhibitors – Treatment Alport’s syndrome – Treatment Short-bowel syndrome Nodal marginal zone B-cell lymphoma – Life with Disease Lymphangiosarcoma – Treatment X-linked lymphoproliferative syndrome – Treatment Mantle cell lymphoma stage II Fragile X syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Emibetuzumab Dorocubicel Tegoprubart Azd3427 Ursodoxicoltaurine Bi 764524 Sacubitril Amiloride Docetaxel Vrdn-001 FLUCLOXACILLIN SODIUM S095035 Deucravacitinib Fluasterone Linperlisib Ciprofloxacin Ganaxolone Ketotifen Hydrogen Fumarate Mps-112 Lonapegsomatropin More therapies…

    Learn about Your Condition

    Osteogenesis imperfecta Red blood cell abnormality Pruritus Macular degeneration Spermatocele Corticobasal degeneration Atrophic vulvovaginitis Vascular malformation Dysmenorrhoea Hepatoblastoma Deep vein thrombosis Hypochondroplasia Antisynthetase syndrome Mastocytosis Arteriovenous malformation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effects of Deucravacitinib for Adults with Inflammatory Skin Conditions (Epidermolysis Bullosa Simplex and Congenital Ichthyoses)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    • Ichthyosis
    Investigated Drugs:
    • Deucravacitinib
    France

  • Study on Tirbanibulin for Treating Superficial Basal Cell Carcinoma in Patients

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Tirbanibulin
    France

  • Study on Acetic Acid for Healing Skin Ulcers in Patients with Biofilm

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Skin ulcer
    Investigated Drugs:
    • Acetic Acid, Glacial
    Spain

  • Study on the Effectiveness of Green Tea Leaf Extract Ointment for Adults with Actinic Keratosis on the Scalp and Face

    Recruiting

    3 1 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • Camellia Sinensis (Green Tea) Leaf Extract
    Germany

  • Long-Term Safety Study of MB-CART19.1, MB-CART20.1, and Zamtocabtagene Autoleucel for Patients with Advanced Melanoma or B-Cell Malignancies

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia refractory
    Investigated Drugs:
    • Mb-Cart20.1
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Zamtocabtagene Autoleucel
    Germany

  • Study on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Aldesleukin
    • Lifileucel
    • Mesna
    Belgium Czechia Finland France Germany Greece +6
Previous Page
1 … 17 18 19 20 21 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!